Zhang Z, Hasegawa Y, Hashimoto D, Senjo H, et al. Gilteritinib enhances graft-versus-leukemia effects against FLT3-ITD mutant
leukemia after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2022 Feb 28. pii: 10.1038/s41409-022-01619.
PMID: 35228711